TPL2 kinase is a suppressor of lung carcinogenesis

Lung cancer is a heterogeneous disease at both clinical and molecular levels, posing conceptual and practical bottlenecks in defining key pathways affecting its initiation and progression. Molecules with a central role in lung carcinogenesis are likely to be targeted by multiple deregulated pathways...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Gkirtzimanaki, Katerina, Gkouskou, Kalliopi K., Oleksiewicz, Urszula, Nikolaidis, Georgios, Vyrla, Dimitra, Liontos, Michalis, Pelekanou, Vassiliki, Kanellis, Dimitris C., Evangelou, Kostantinos, Stathopoulos, Efstathios N., Field, John K., Tsichlis, Philip N., Gorgoulis, Vassilis, Liloglou, Triantafillos, Eliopoulos, Aristides G.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: National Academy of Sciences 2013
Gaiak:
PNAS Plus
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3631618/
https://ncbi.nlm.nih.gov/pubmed/23533274
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1215938110
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak